-
公开(公告)号：KR1019920006911B1
公开(公告)日：1992-08-22
申请号：KR1019890008200
申请日：1989-06-14
Applicant: 신풍제약주식회사
IPC: A61K31/54
Abstract: A stable piroxicam injection compsn.contains piroxicam as an effective ingredient, 1.1 - 1.2 mole of L-arginine or L-lysine (relative to 1 mole piroxicam) as a solubilizing agent, 15-25 W/V % of propylene glycol mixture and 1-2 W/V % of polyvinyl pyrrolidone. Also claimed is the prepn. of the compsn. which comprises dissolving piroxicam with L-arginine, L-lysine and propylene glycol in distilled water for injection, and adding polyvinyl pyrrolidone into the obtd. soln as a stabilizer. Piroxicam is useful as a nonsteroidal antiphlogistic analgesic.
Abstract translation: 稳定的吡罗昔康注射剂含有炎痛喜糖作为有效成分，1.1-1.2摩尔L-精氨酸或L-赖氨酸（相对于1摩尔吡罗昔康）作为增溶剂，15-25W / V％的丙二醇混合物和1 -2W / V％的聚乙烯吡咯烷酮。 还声称是prepn。 的compsn。 其中包括将吡罗昔康与L-精氨酸，L-赖氨酸和丙二醇溶解在用于注射的蒸馏水中，并将聚乙烯吡咯烷酮加入到该溶液中。 soln作为稳定剂。 吡罗昔康作为非甾体类消炎止痛药有用。
-
Search Results
3
records
(took 0.015 seconds)
